Answer
Eribulin Baxter is indicated for adults with locally advanced or metastatic breast cancer progressing after at least one chemotherapy regimen for advanced disease, whose prior therapy included an anthracycline and a taxane in the adjuvant or metastatic setting unless unsuitable for these treatments.
Sources for this answer
- Eribulin Baxter 0.44 mg/mL solution for injectionBaxter Healthcare Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked